Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mixed Lineage Kinase 2 (MLK2) is a serine/threonine protein kinase belonging to the mixed lineage kinase (MLK) family and the MAP3K superfamily. It is primarily expressed in the brain and plays a role in regulating cell migration, invasion, cell cycle progression, apoptosis, and neuronal function. MLK2 acts as an upstream activator of MAP kinase pathways. It has been implicated in neurodegenerative conditions and cancer. Its activity is regulated via intramolecular interactions.
Kinase inhibitor (potential)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mixed Lineage Kinase 2.